Related Experiment Videos
FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells
Min Zhu1, Qing-Jun Zhang, Lin Wang
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Objectives:
FoxO proteins are transcription factors involved in varieties of cellular processes, including immune cell homeostasis, cytokine production, anti-oxidative stress, and cell proliferation and differentiation. Although these processes are implicated in the development of atherosclerosis, very little is known about the role of FoxO proteins in the context of atherosclerosis. Our objectives were to determine whether and how inactivation of Foxo4, a member of the FoxO family, in vivo promotes atherosclerosis.
Methods And Results:
Apolipoprotein E-deficient (apoE(-/-)) mice were crossbred with animals lacking Foxo4 (Foxo4(-/-)). After 10 weeks on a high fat diet (HFD), Foxo4(-/-)apoE(-/-) mice showed elevated atherosclerosis and increased amount of macrophages and T cells in the plaque compared to apoE(-/-) mice. Bone marrow transplantations of chimeric C57B/6 mice reconstituted with either wild-type or Foxo4(-/-) bone marrows indicate that Foxo4-deficiency in bone marrow derived cells sufficiently promoted atherosclerosis. Foxo4-null macrophages produced elevated inflammatory cytokine IL-6 and levels of reactive oxygen species (ROS) in response to lipopolysaccharides in vitro. Serum levels of IL-6 were upregulated in HFD-fed Foxo4(-/-)apoE(-/-) mice compared to those of apoE(-/-) mice.
Conclusions:
FoxO4 inhibits atherosclerosis through bone marrow derived cells, possibly by inhibition of ROS and inflammatory cytokines that promote monocyte recruitment and/or retention.
Insights
FoxO4 deficiency in bone marrow cells exacerbates atherosclerosis by increasing inflammation and oxidative stress. This study reveals FoxO4
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Immunology
Background:
- FoxO proteins regulate critical cellular functions like immune homeostasis and oxidative stress response.
- Their role in atherosclerosis development remains largely unexplored.
- FoxO4 is a key member of the FoxO family.
Purpose of the Study:
- To investigate the role of FoxO4 inactivation in promoting atherosclerosis.
- To determine if FoxO4 deficiency in vivo impacts atherosclerotic plaque development.
Main Methods:
- Crossbreeding apolipoprotein E-deficient (apoE(-/-)) mice with Foxo4-deficient (Foxo4(-/-)) mice.
- High-fat diet (HFD) induction and analysis of atherosclerotic lesions.
- Bone marrow transplantation experiments in chimeric mice.
- In vitro studies on macrophage inflammatory responses and reactive oxygen species (ROS) production.
Main Results:
- Foxo4(-/-)apoE(-/-) mice exhibited significantly elevated atherosclerosis compared to apoE(-/-) controls after HFD.
- Increased macrophage and T cell infiltration was observed in atherosclerotic plaques of Foxo4-deficient mice.
- Foxo4-deficient bone marrow cells promoted atherosclerosis, and Foxo4-null macrophages showed heightened IL-6 and ROS production in vitro.
- Serum IL-6 levels were upregulated in HFD-fed Foxo4(-/-)apoE(-/-) mice.
Conclusions:
- FoxO4 acts as an inhibitor of atherosclerosis development.
- Its inhibitory effect is mediated through bone marrow-derived cells.
- FoxO4 may suppress atherosclerosis by reducing ROS and inflammatory cytokines, thereby limiting monocyte recruitment and retention.
Related Concept Videos
Osteoclasts in Bone Remodeling
Inflammation
Regulation of Angiogenesis and Blood Supply
Cholesterol: Significance and Regulation
Considering cholesterol and...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...